Ads
-
Related paper
- Cost-Effectiveness of Idelalisib-Rituximab for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
- CLINICAL EFFICIENCY OF COMBINATION OF BENDAMUSTINE + RITUXIMAB IN FIRST LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND PATIENTS WITH RECURRENT DISEASE
- Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?
- The use of chlorbutin in the treatment of chronic lymphocytic leukemia
- Acute myeloid leukemia in a chronic lymphocytic leukemia patient: diagnostic challenge (clinical case)
- Vasculitis Associated with Chronic Lymphocytic Leukemia
- Spontaneous regression of chronic lymphocytic leukemia
- The Microenvironment as a Target for Therapy in Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia in Elderly Patients: Own Experience
- DISORDERS IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
